Wang et al. 115 developed an albumin-based multifunctional nanoplatform, IR780-NLG919-TPZ NPs, specifically designed to overcome the impediments to anti-tumor immunity posed by the immunosuppressive tumor microenvironment (TME) while simultaneously inducing ICD. This evidence concerns the gene ALB and neoplasm.